BioXcel Therapeutics Inc. (BTAI) Rose 5.36% or 0.32 To Price $6.29 On Thursday

BioXcel Therapeutics Inc. (BTAI) rose 5.36% or 0.32 to $6.29. It is about 35971 shares traded, which is 15.68% compare to the average total volume 229446. The market cap of BTAI is $98.41 million. The year to date change is 76.42%. The 52 week price range is from $2.41 to $14.79. Price of BTAI have changed 18.92% during last week. It have changed 28.08% over last month, -11.69% over last 3 months, -45.87% over last 6 months and -45.87% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BTAI is 4.86. It is -22.73% below current price. The 200-day Moving Averages for BTAI is 8.06. It is 28.14% above current price. The 52-week High is 14.79. It is 135.14% from the current price. The 52-week Low is 2.41. It is -61.69% from current price.

There are some statistics of BTAI. It is has market cap $98.41 million. The share outstanding is 15.65 million. The average volume is 229446. The percent of top 15 Institution holding is 44.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BTAI is -32.13%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BTAI is -30.76%.


Share this post